The American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care has issued guidance and recommendations on adolescent pregnancy, contraception, and sexual activity. The College supports access for adolescents to all contraceptive methods approved by the FDA and supports the implementation of successful programs that result in measureable changes in adolescent contraceptive practices and sexual behavior. Among their recommendations and conclusions:
- Pregnancy in adolescents has decreased largely because adolescents are becoming more effective contraceptive users.
- Support access for adolescents and young adults to all contraceptive methods approved by the FDA.
- Because of the safety and effectiveness of long-acting reversible contraceptive (LARC) methods, the College and the American Academy of Pediatrics (AAP) endorse the use of intrauterine devices (IUDs) and implants as contraceptive options for adolescents.
- The College, the Centers for Disease Control and Prevention (CDC), and AAP also recommend that LARC methods be discussed with pregnant adolescents.
- For adolescents who choose a LARC method, initiation should be offered immediately after delivery, pregnancy loss, or abortion.
- Dual method use—pairing condoms with more effective contraceptive methods to protect against sexually transmitted infections (STIs) and unwanted pregnancy—is the ideal contraceptive practice for adolescents.
Adolescent pregnancy, contraception, and sexual activity. Committee Opinion No. 699. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2017;129:e142–9.
This Week's Must Reads
Must Reads in Clinical Guidelines
ACOG: Chronic Hypertension in Pregnancy, Obstet Gynecol; ePub 2019 Jan; Vidaeff, et al
ACOG Guidelines: Pregestational Diabetes Mellitus, Obstet Gynecol; ePub 2018 Dec; ACOG, et al
Management of Early Pregnancy Loss, Obstet Gynecol; ePub 2018 Nov; ACOG
Prophylactic Antibiotic Use in Labor & Delivery, Obstet Gynecol; 2018 Sep; Coleman, et al
USPSTF on Screening for Cervical Cancer, JAMA; 2018 Aug 21; US Preventive Services Task Force